Fuxing Zhao - Concepedia

Author

Fuxing Zhao

Qinghai University Affiliated Hospital ORCID

Also Known As

F Zhao, Fanghe Zhao, Fu-Xing Zhao, Fuxing Zhao, Shifeng Huang, Zhao F, Zhao, Fuxing

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Qinghai University Affiliated Hospital Qinghai University Qinghai No.3 People's Hospital Qinghai Provincial Peoples Hospital Ningxia Medical University

About

Fuxing Zhao is an author at Qinghai University Affiliated Hospital specializing in medicine, breast cancer, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	145
2	Cell Biology	2	2	30
3	Engineering	1	1	33
4	Public Health	1	1	12
5	Biostatistics	1	1	12

Fuxing Zhao

Publications

288

Citations

H-Index

Page 1

	Year	Citations
Cosegregation of the ND4 G11696A mutation with the LHON-associated ND4 G11778A mutation in a four generation Chinese family Jia Qu, Ronghua Li, Xiangtian Zhou, Mitochondrion Generation Chinese FamilyAllelic VariantGenetic DisorderGeneticsNd4 G11696a Mutation	2006	54
SBCNet: Scale and Boundary Context Attention Dual-Branch Network for Liver Tumor Segmentation Kai‐Ni Wang, S. Li, Zhenyu Bu, IEEE Journal of Biomedical and Health Informatics Precise SegmentationMachine LearningTumor SegmentationEngineeringPathology	2024	33
Maize Ethylene Response Factor ZmERF061 Is Required for Resistance to Exserohilum turcicum Zhenyuan Zang, Fuxing Zhao, Wei Yang Frontiers in Plant Science	2021	29
Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis Mingqiang Shi, Zhoujuan Li, Guoshuang Shen, Cancer Pathogenesis and Therapy	2023	24
Genome-wide analysis of gibberellin-dioxygenases gene family and their responses to GA applications in maize Jiabin Ci, Xingyang Wang, Qi Wang, PLoS ONE	2021	23
Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment Xingfa Huo, Guoshuang Shen, Jinming Li, Gene Gtpase Imap FamilyImmune-related Prognostic BiomarkerBreast OncologyCancer ImmunosurveillanceImmunology	2021	17
S-1/temozolomide versus S-1/temozolomide plus thalidomide in advanced pancreatic and non-pancreatic neuroendocrine tumours (STEM): A randomised, open-label, multicentre phase 2 trial Yihebali Chi, Lijie Song, Weili Liu, EClinicalMedicine Neuro-oncologyEndocrine OncologySurgical OncologyOncologyPancreatic Cancer	2022	16
GCR1 Positively Regulates UV-B- and Ethylene-Induced Stomatal Closure via Activating GPA1-Dependent ROS and NO Production Xue Li, Qi Fu, Fuxing Zhao, International Journal of Molecular Sciences	2022	14
Expression and clinical prognostic value of CYB561 in breast cancer Xiaofeng Zhou, Guoshuang Shen, Dengfeng Ren, Journal of Cancer Research and Clinical Oncology Breast OncologyMedicinePathologyCancer GenomicsBreast Cancer	2022	13
Watson for oncology decision system for treatment consistency study in breast cancer Yaobang Liu, Xingfa Huo, Qi Li, Clinical and Experimental Medicine Breast OncologyHealth InformaticsMedicineOncology Decision SystemTreatment Consistency Study	2022	12

Page 1